Eurofins expands its food testing laboratory capacity in New Zealand

Eurofins Scientific (EUFI.PA), the global leader in food and environment testing, announces the completion of the extensive rebuild of its Auckland microbiology, chemistry and soil testing laboratory into a large, state-of-the-art facility with total laboratory surface of 3,700m². The laboratory was officially opened on Friday, the 16th of May by the Hon. Steven Joyce, New Zealand's Minister of Economic Development, Science and Innovation.

The investment, started shortly after the acquisition of NZ Labs by Eurofins in 2012, involved upgrading the site in Auckland to modern Eurofins standards, as well as adding a 2,000m² laboratory wing that significantly expands the laboratory's capacity. Eurofins has also expanded the laboratory's capabilities by adding a further 120 analytical methods for food and dairy matrices, including analyses for infant formula label claims. The laboratory will serve as one of the Group's main hubs for dairy testing in the region, and part of Eurofins' network of dairy laboratories in Denmark, Netherlands, Poland, Brazil, USA and China.

At present, Eurofins' footprint in New Zealand includes laboratories in Hamilton, Wellington and Christchurch providing food, environmental and pharmaceutical products testing, as well as auditing services. In addition, Eurofins operates agroscience laboratories in Hamilton and Sydney [in neighboring Australia], offering comprehensive testing services for herbicide, pesticide and veterinary medicine residues in a wide range of matrices.

Comment from Dr. Matthias Wilbur-Weber, Eurofins Group Executive Vice President for Asia Pacific: "This investment underpins our commitment to support the food and dairy markets of New Zealand. We intend to continue strengthening our local footprint by making the full range of services and capabilities of the Eurofins Group available to our laboratories in New Zealand, and the rest of the Asia Pacific region."

For more information please visit www.eurofins.co.nz or contact:

Notes for the editor:

Eurofins - a global leader in bio-analysis

Eurofins Scientific is the world leader in food and pharmaceutical products testing. It is also number one in the world in the field of environmental laboratory services and one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services.

With over 15,000 staff in more than 190 laboratories across 36 countries, Eurofins offers a portfolio of over 100,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.

Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.

As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.

The shares of Eurofins Scientific are listed on the NYSE Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).

Important disclaimer:

This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgement of Eurofins Scientific’ management as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the information available to the Company’s management as of the date of publication, but no guarantee can be made as to their validity.